Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Gross Profit: 2014-2020

Historic Gross Profit for Larimar Therapeutics (LRMR) over the last 6 years, with Mar 2020 value amounting to -$301,000.

  • Larimar Therapeutics' Gross Profit rose 39.80% to -$301,000 in Q1 2020 from the same period last year, while for Mar 2020 it was -$1.6 million, marking a year-over-year increase of 19.23%. This contributed to the annual value of -$1.8 million for FY2019, which is 6.95% up from last year.
  • As of Q1 2020, Larimar Therapeutics' Gross Profit stood at -$301,000, which was up 16.85% from -$362,000 recorded in Q4 2019.
  • Larimar Therapeutics' Gross Profit's 5-year high stood at -$8,000 during Q4 2017, with a 5-year trough of -$500,000 in Q1 2019.
  • Its 3-year average for Gross Profit is -$440,556, with a median of -$466,000 in 2018.
  • Its Gross Profit has fluctuated over the past 5 years, first spiked by 91.75% in 2017, then tumbled by 6,137.50% in 2018.
  • Over the past 5 years, Larimar Therapeutics' Gross Profit (Quarterly) stood at -$97,000 in 2016, then skyrocketed by 91.75% to -$8,000 in 2017, then slumped by 6,137.50% to -$499,000 in 2018, then grew by 27.45% to -$362,000 in 2019, then soared by 39.80% to -$301,000 in 2020.
  • Its Gross Profit was -$301,000 in Q1 2020, compared to -$362,000 in Q4 2019 and -$426,000 in Q3 2019.